Breakthrough discovery could boost stem-cell transplants by improving cell mobilization

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body’s different blood cells.

Australia’s BioCina and NovaCina join forces to make one CDMO

Private investment firm Bridgewest is combining its Australia-based biologics CDMO BioCina and its sterile injectable manufacturer NovaCina into one company. The new CDMO will continue

January 15, 2025

Shortwave Life Sciences Reports “Positive” Drug Safety Results | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – September 19, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on

September 19, 2024

Steris to sell dental segment for $787.5M

Dive Brief: Steris has agreed to sell its dental business to investment firm Peak Rock Capital for $787.5 million in cash, the companies said on

April 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.